Research Article
Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial
Table 1
Subjects’ clinical characteristics.
| | Characteristics | No. (%) | value | | Experimental group () | Control group () | Total () |
| | Age, mean (SD) (years) | 61.4 (10.0) | 61.3 (11.8) | 62.4 (11.0) | 0.24 | | Gender | | Male | 54 (60%) | 54 (60%) | 108 (60%) | 1 | | Female | 36 (40%) | 36 (40%) | 72 (40%) | | Marriage | | Married | 76 (84.4%) | 73 (81.1%) | 149 (82.8%) | 0.645 | | Divorced | 11 (12.2%) | 15 (16.7%) | 26 (14.4%) | | Not married | 3 (3.3%) | 2 (2.2%) | 5 (2.8%) | | Education | | Elementary school | 18 (20%) | 14 (15.6%) | 32 (17.8%) | 0.901 | | Junior high school | 13 (14.4%) | 12 (13.3%) | 25 (13.9%) | | Senior high school | 25 (27.8%) | 30 (33.3%) | 55 (30.6%) | | Bachelor degree | 21 (23.3%) | 20 (22.2%) | 41 (22.8%) | | Others | 13 (14.4%) | 14 (15.6%) | 27 (15%) | | Occupation | | Civil servant | 7 (7.8%) | 4 (4.4%) | 11 (6.1%) | 0.138 | | Entrepreneur | 14 (15.6%) | 6 (6.7%) | 20 (11.1%) | | Private employee | 10 (11.1%) | 10 (11.1%) | 20 (11.1%) | | Retired | 18 (20%) | 28 (31.1%) | 46 (25.6%) | | Unemployment | 14 (15.6%) | 21 (23.3%) | 35 (19.4%) | | Others | 27 (30%) | 21 (23.3%) | 48 (26.7%) | | Type of health financing | | Public insurance | 64 (71.1%) | 64 (71.1%) | 128 (71.1%) | 0.498 | | Private insurance | 1 (1.1%) | 0 (0%) | 1 (0.6%) | | Fee for service | 23 (25.6%) | 21 (23.3%) | 44 (24.4%) | | Company insurance | 2 (2.2%) | 5 (5.6%) | 7 (3.9%) | | Comorbidities | | Hypertension | 49 (54.4%) | 47 (52.2%) | 96 (53.3%) | 0.765 | | Diabetes mellitus | 30 (33.3%) | 30 (33.3%) | 60 (33.3%) | 1 | | Cardiovascular disease | 19 (21.1%) | 20 (22.2%) | 39 (21.7%) | 0.856 | | Gastrointestinal disease | 3 (3.3%) | 8 (8.9%) | 11 (6.1%) | 0.12 | | Others | 4 (4.4%) | 7 (7.8%) | 11 (6.1%) | 0.351 | | Concomitant medications | | Antihypertensive medication | 45 (50%) | 45 (50%) | 90 (50%) | 1 | | Antidiabetic medication | 29 (32.2%) | 30 (33.3%) | 59 (32.8%) | 0.874 | | Antiplatelet | 84 (93.3%) | 86 (95.6%) | 170 (94.4%) | 0.515 | | PPI/H2 blocker | 2 (2.2%) | 1 (1.1%) | 3 (1.7%) | 1 | | Anticoagulant | 0 (0%) | 0 (0%) | 0 (0%) | 1 | | Muscle strength | | 0-no contraction | 2 (2.2%) | 0 (0%) | 2 (1.1%) | 0.044 | | 1-visible muscle contraction without limb movement | 4 (4.4%) | 1 (1.1%) | 5 (2.8%) | | 2-active movement, but not against gravity | 12 (13.3%) | 10 (11.1%) | 22 (12.2%) | | 3-active movement against gravity | 26 (28.9%) | 15 (16.7%) | 41 (22.8%) | | 4-active movement against gravity and resistance | 43 (47.8%) | 55 (61.1%) | 98 (54.4%) | | 5-normal muscle power | 3 (3.3%) | 9 (10%) | 12 (6.7%) | | Location of lesions on CT scan | | Cortex | 32 (35.6%) | 29 (32.2%) | 61 (33.9%) | 0.912 | | Subcortex | 42 (46.7%) | 44 (48.9%) | 86 (47.8%) | | Cortex and subcortex | 16 (17.8%) | 17 (18.9%) | 33 (18.3%) | | Atrophy on CT scan | | Visible atrophy | 24 (26.7%) | 28 (31.1%) | 52 (28.9%) | 0.48 | | No atrophy | 66 (73.3%) | 62 (68.9%) | 128 (71.1%) | | Number of lesions on CT scan | | Single | 53 (58.9%) | 49 (54.4%) | 102 (56.7%) | 0.504 | | Multiple | 37 (41.1%) | 41 (45.6%) | 78 (43.3%) | | CDT, mean (SD) | 2.6 (1.5) | 2.2 (1.6) | 2.4 (1.5) | 0.229 | | Length of stay, median (range) (days) | 4 (0-16) | 3 (2-13) | 4 (0-24) | 0.15 |
|
|
Data are presented as and . Abbreviations: CDT: Clock Drawing Test; CT: computed tomography; GCS: Glasgow Coma Scale. |
